- Home
- ORGO vs EVN Comparison
ORGO vs EVN Comparison
Compare ORGO & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- EVN
- Stock Information
- Founded
- ORGO 1985
- EVN 1998
- Country
- ORGO United States
- EVN United States
- Employees
- ORGO N/A
- EVN N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- EVN Investment Bankers/Brokers/Service
- Sector
- ORGO Health Care
- EVN Finance
- Exchange
- ORGO Nasdaq
- EVN Nasdaq
- Market Cap
- ORGO 539.1M
- EVN 444.3M
- IPO Year
- ORGO N/A
- EVN N/A
- Fundamental
- Price
- ORGO $5.14
- EVN $10.89
- Analyst Decision
- ORGO Buy
- EVN
- Analyst Count
- ORGO 3
- EVN 0
- Target Price
- ORGO $8.00
- EVN N/A
- AVG Volume (30 Days)
- ORGO 3.1M
- EVN 101.2K
- Earning Date
- ORGO 11-06-2025
- EVN 01-01-0001
- Dividend Yield
- ORGO N/A
- EVN 4.78%
- EPS Growth
- ORGO N/A
- EVN N/A
- EPS
- ORGO N/A
- EVN 0.34
- Revenue
- ORGO $465,218,000.00
- EVN N/A
- Revenue This Year
- ORGO $2.51
- EVN N/A
- Revenue Next Year
- ORGO $25.45
- EVN N/A
- P/E Ratio
- ORGO N/A
- EVN $29.94
- Revenue Growth
- ORGO 2.24
- EVN N/A
- 52 Week Low
- ORGO $2.61
- EVN $8.64
- 52 Week High
- ORGO $7.08
- EVN $10.45
- Technical
- Relative Strength Index (RSI)
- ORGO 50.25
- EVN 44.22
- Support Level
- ORGO $5.09
- EVN $10.75
- Resistance Level
- ORGO $5.83
- EVN $11.00
- Average True Range (ATR)
- ORGO 0.50
- EVN 0.09
- MACD
- ORGO -0.08
- EVN -0.01
- Stochastic Oscillator
- ORGO 3.02
- EVN 32.96
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.